TMCnet News
SmarTrend Watching for Potential Pullback in Shares of MAP Pharmaceuticals After 58.60% GainJan 23, 2013 (SmarTrend(R) News Watch via COMTEX) -- MAP Pharmaceuticals (NASDAQ:MAPP) traded in a range yesterday that spanned from a low of $24.68 to a high of $24.77. Yesterday, the shares gained 58.6%, which took the trading range above the 3-day high of $15.87 on volume of 45.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. In the past 52 weeks, shares of MAP Pharmaceuticals have traded between a low of $10.54 and a high of $24.77 and are now at $24.71, which is 134% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.2%. SmarTrend recommended that subscribers consider buying shares of MAP Pharmaceuticals on November 23rd, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $15.11. Since that recommendation, shares of MAP Pharmaceuticals have risen 3.1%. We continue to monitor MAPP for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |